Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study.

Anderlini P, Wu J, Gersten I, Ewell M, Tolar J, Antin JH, Adams R, Arai S, Eames G, Horwitz ME, McCarty J, Nakamura R, Pulsipher MA, Rowley S, Leifer E, Carter SL, DiFronzo NL, Horowitz MM, Confer D, Deeg HJ, Eapen M.

Lancet Haematol. 2015 Sep;2(9):e367-75. doi: 10.1016/S2352-3026(15)00147-7. Epub 2015 Sep 2.

2.

Evolving hematopoietic stem cell transplantation strategies in severe aplastic anemia.

Dietz AC, Lucchini G, Samarasinghe S, Pulsipher MA.

Curr Opin Pediatr. 2016 Feb;28(1):3-11. doi: 10.1097/MOP.0000000000000299. Review.

3.

Conditioning with rabbit versus horse ATG dramatically alters clinical outcomes in identical twins with severe aplastic anemia transplanted with the same allogeneic donor.

Vo PT, Pantin J, Ramos C, Cook L, Cho E, Kurlander R, Khuu H, Barrett J, Leitman S, Childs RW.

J Hematol Oncol. 2015 Jun 26;8:78. doi: 10.1186/s13045-015-0173-x.

4.

Advances in sickle cell therapies in the hydroxyurea era.

Field JJ, Nathan DG.

Mol Med. 2014 Dec 16;20 Suppl 1:S37-42. doi: 10.2119/molmed.2014.00187. Review.

5.

Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.

Hsieh MM, Fitzhugh CD, Weitzel RP, Link ME, Coles WA, Zhao X, Rodgers GP, Powell JD, Tisdale JF.

JAMA. 2014 Jul 2;312(1):48-56. doi: 10.1001/jama.2014.7192.

6.

Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria.

Pantin J, Tian X, Geller N, Ramos C, Cook L, Cho E, Scheinberg P, Vasu S, Khuu H, Stroncek D, Barrett J, Young NS, Donohue T, Childs RW.

Biol Blood Marrow Transplant. 2014 Sep;20(9):1435-9. doi: 10.1016/j.bbmt.2014.05.012. Epub 2014 May 17.

7.

Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigens.

Patel SR, Zimring JC.

Transfus Med Rev. 2013 Oct;27(4):241-8. doi: 10.1016/j.tmrv.2013.08.002. Epub 2013 Oct 3. Review.

8.

Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes.

Pantin J, Tian X, Shah AA, Kurlander R, Ramos C, Cook L, Khuu H, Stroncek D, Leitman S, Barrett J, Donohue T, Young NS, Geller N, Childs RW.

Am J Hematol. 2013 Oct;88(10):874-82. doi: 10.1002/ajh.23526. Epub 2013 Sep 3.

9.

CTLA4-Ig prevents alloantibody production and BMT rejection in response to platelet transfusions in mice.

Gilson CR, Patel SR, Zimring JC.

Transfusion. 2012 Oct;52(10):2209-19. doi: 10.1111/j.1537-2995.2011.03550.x. Epub 2012 Feb 10.

10.

Mechanisms of alloimmunization and subsequent bone marrow transplantation rejection induced by platelet transfusion in a murine model.

Patel SR, Smith NH, Kapp L, Zimring JC.

Am J Transplant. 2012 May;12(5):1102-12. doi: 10.1111/j.1600-6143.2011.03959.x. Epub 2012 Feb 2.

11.

Clinical implications of chimerism after allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases.

Park M, Koh KN, Seo JJ, Im HJ.

Korean J Hematol. 2011 Dec;46(4):258-64. doi: 10.5045/kjh.2011.46.4.258. Epub 2011 Dec 27.

12.

Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now.

Hsieh MM, Fitzhugh CD, Tisdale JF.

Blood. 2011 Aug 4;118(5):1197-207. doi: 10.1182/blood-2011-01-332510. Epub 2011 May 31. Review.

13.

Clinical management of aplastic anemia.

Dezern AE, Brodsky RA.

Expert Rev Hematol. 2011 Apr;4(2):221-30. doi: 10.1586/ehm.11.11. Review.

14.

Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia.

Anderlini P, Acholonu SA, Okoroji GJ, Bassett RE, Shpall EJ, Qazilbash MH, Popat UR, Worth LL, Giralt SA, Champlin RE.

Leuk Lymphoma. 2011 Jan;52(1):137-41. doi: 10.3109/10428194.2010.524328. Epub 2010 Oct 12. No abstract available.

15.

Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party.

Bacigalupo A, Socie' G, Lanino E, Prete A, Locatelli F, Locasciulli A, Cesaro S, Shimoni A, Marsh J, Brune M, Van Lint MT, Oneto R, Passweg J; Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation..

Haematologica. 2010 Jun;95(6):976-82. doi: 10.3324/haematol.2009.018267. Epub 2010 May 21.

16.

Specific factors influence the success of autologous and allogeneic hematopoietic stem cell transplantation.

Gonçalves TL, Benvegnú DM, Bonfanti G.

Oxid Med Cell Longev. 2009 Apr-Jun;2(2):82-7.

17.

Allogeneic hematopoietic stem-cell transplantation for sickle cell disease.

Hsieh MM, Kang EM, Fitzhugh CD, Link MB, Bolan CD, Kurlander R, Childs RW, Rodgers GP, Powell JD, Tisdale JF.

N Engl J Med. 2009 Dec 10;361(24):2309-17. doi: 10.1056/NEJMoa0904971.

18.

Hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: long-term results of a retrospective study on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

Santarone S, Bacigalupo A, Risitano AM, Tagliaferri E, Di Bartolomeo E, Iori AP, Rambaldi A, Angelucci E, Spagnoli A, Papineschi F, Tamiazzo S, Di Nicola M, Di Bartolomeo P.

Haematologica. 2010 Jun;95(6):983-8. doi: 10.3324/haematol.2009.017269. Epub 2009 Dec 8.

19.

Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen.

Maury S, Bacigalupo A, Anderlini P, Aljurf M, Marsh J, Socié G, Oneto R, Passweg JR; Severe Aplastic Anemia Working Party, European Group for Blood and Marrow Transplantation (EBMT-SAAWP)..

Haematologica. 2009 Sep;94(9):1312-5. doi: 10.3324/haematol.2009.006916.

20.

Transfusion of minor histocompatibility antigen-mismatched platelets induces rejection of bone marrow transplants in mice.

Patel SR, Cadwell CM, Medford A, Zimring JC.

J Clin Invest. 2009 Sep;119(9):2787-94. doi: 10.1172/JCI39590. Epub 2009 Aug 10.

Supplemental Content

Support Center